In CD, the NOD2 gene on chromosome 16 and several additional risk variants identified through genome-wide association studies (GWAS)—with key insights from the International Inflammatory Bowel Disease Genetics Consortium—have enhanced our understanding of the pathobiology of the disease. This evidence concerns the gene NOD2 and inflammatory bowel disease.